Intestinal tissue damage in IBD is mediated by cytokines produced in the inflammatory microenvironment, and blocking cytokine function, such as TNF-α, IL-1β, IL-6, and IL-12, is a major target of therapeutic intervention in IBD [26]. This evidence concerns the gene TNF and inflammatory bowel disease.